13. HRVATSKI
ONKOLOŠKI
KONGRES

03.-06.09.2020. VIRTUALNI KONGRES

HEMATOLOGIC TOXICITY OF CYCLIN DEPENDENT KINASE 4/6 (CDK4/6) INHIBITORS PALBOCICLIB AND RIBOCICLIB DURING FIRST THREE CYCLES OF 1ST LINE TREATMENT OF METASTATIC BREAST CANCER - RETROSPECTIVE ANALYSIS IN SINGLE CENTRE

Autor: Ana Majić

Odgovori

Vaša adresa e-pošte neće biti objavljena. Obavezna polja su označena sa *